Related Experiment Videos
Synthesis and carcinogenicity of compounds related to 6-hydroxymethylbenzo(a)pyrene
Journal of Medicinal Chemistry
|June 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preservation of drugs.
Ancient science of life·2012
FTIR spectra and mechanical strength analysis of some selected rubber derivatives.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2007
9-Sulfooxymethylanthracene is an ultimate electrophilic and carcinogenic form of 9-hydroxymethylanthracene.
Biochemical and biophysical research communications·1998
Carcinogenicity of 1-hydroxy-3-methylcholanthrene and its electrophilic sulfate ester 1-sulfooxy-3-methylcholanthrene in Sprague-Dawley rats.
Biochemical and biophysical research communications·1998
6-sulfooxymethylbenzo[a]pyrene is an ultimate electrophilic and carcinogenic form of the intermediary metabolite 6-hydroxymethylbenzo[a]pyrene.
Biochemical and biophysical research communications·1997
7-Sulfooxymethylbenz[a]anthracene is an ultimate electrophilic and carcinogenic form of 7-hydroxymethylbenz[a]anthracene.
Biochemical and biophysical research communications·1997
Structural and Mechanistic Studies of ADEPs Yield Potent Antibacterials and a Drug Formulation Strategy for Tuberculosis.
Journal of medicinal chemistry·2026
A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.
Journal of medicinal chemistry·2026
From Fragment Hit to Clinical Candidate: Discovery of Dual H1R/H4R Ligands with Superior Efficacy in Allergic Conjunctivitis.
Journal of medicinal chemistry·2026
Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria.
Journal of medicinal chemistry·2026
Discovery of a Covalent NLRP3 LRR-Domain Probe: Reversing Renal Fibrosis via Immunometabolic Reprogramming in Organoid and Murine Models.
Journal of medicinal chemistry·2026
Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.
Journal of medicinal chemistry·2026